Clinical trials evaluating semaglutide safety, including the SUSTAIN and STEP trial programs which enrolled thousands of participants, did not identify UTIs as a significant adverse event associated with the medication
Store the vial in a cool, dry place between 2-8 C, protected from light, to preserve peptide stability
Because of these limitations, there was a desire for a GLP-1 agonist that could be taken orally at any time of the day without any food or water restrictions
TR CON CBS MAY2022 About This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Mounjaro (tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) injection as a treatment to improve glycemic control in adults with type 2 diabetes, the timeline for supply of Mounjaro to become available, and certain other milestones and ongoing clinical trials of Mounjaro and reflects References Mounjaro
Inhibiting the release of glucagon by the pancreas
The company noted that VK2735 is being developed in both oral and injectable formulations for metabolic disorders, underscoring its position in the rapidly expanding GLP-1 obesity-treatment landscape